Close Menu
Home » Revocation of Broad Institute CRISPR Patent Upheld in Europe

Revocation of Broad Institute CRISPR Patent Upheld in Europe

Jan 17, 2020
|
staff reporter

This story has been updated to include comments from ERS Genomics.

NEW YORK – The European Patent Office (EPO) Board of Appeal has upheld the revocation of a Broad Institute CRISPR patent in Europe.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Metabolite Trail

The Economist reports that it is increasingly easier to analyze the metabolites people give off, potentially revealing personal information about them.

Just a Few Changes...

A controversial paper on the gender gap in science has been corrected, according to BuzzFeed News.

Not Meeting Standards

The Los Angeles Times reports that only a third of California students meet the state's new science standards.

Science Studies Examine Archaic Admixture in West Africans, Variant Linked to Cannabis Dependence Risk

In Science this week: evidence of interbreeding between the ancestors of West Africans and an unknown archaic human, and more.

What's Popular?

In Business News

  1. Bio-Rad Laboratories Products Indirectly Infringe 10x Genomics Patents, USITC Confirms

  2. OncoDNA Closes $20.6M Funding Round

  3. Exact Sciences Q4 Revenues Up 107 Percent

  4. Yourgene Health Gets Australian Approval for Chemotoxicity Assay

  5. Bio-Rad Q4 Revenues up 1 Percent, Miss Analysts' Estimates

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.